TLR4 and osteoarthritis: Similarly, other DAMPs were shown to propel inflammation through the activation of TLR4 in rheumatoid and osteoarthritis, which highlights the inhibition of TLR4-mediated signaling as a potential therapeutic option [75,76,77].